Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Maytansinoid-conjugated human monoclonal antibody against mesothelin

EU orphan designation number: EU/3/12/1073   
Active ingredient: Maytansinoid-conjugated human monoclonal antibody against mesothelin
Indication: Treatment of malignant mesothelioma
Sponsor: Bayer Pharma AG
Müllerstrasse 178, 13353 Berlin, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/12/2012 Orphan designation EMA/OD/063/12 (2012)9392 of 06/12/2012